PRKCB and non-small cell lung carcinoma: PRKCB is involved in cancer-related pathways and immune cell receptor signaling pathways, such as B cell receptor signaling, T cell receptor signaling, and VEGF signaling, and is associated with immune cell infiltration in NSCLC (36, 37).